149 related articles for article (PubMed ID: 31791181)
1. Interleukin-17 and lupus: enough to be a target? For which patients?
Robert M; Miossec P
Lupus; 2020 Jan; 29(1):6-14. PubMed ID: 31791181
[TBL] [Abstract][Full Text] [Related]
2. The role of IL-17 in systemic lupus erythematosus and its potential as a therapeutic target.
Koga T; Ichinose K; Kawakami A; Tsokos GC
Expert Rev Clin Immunol; 2019 Jun; 15(6):629-637. PubMed ID: 30874446
[TBL] [Abstract][Full Text] [Related]
3. Current Insights and Future Prospects for Targeting IL-17 to Treat Patients With Systemic Lupus Erythematosus.
Koga T; Ichinose K; Kawakami A; Tsokos GC
Front Immunol; 2020; 11():624971. PubMed ID: 33597953
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-17 and systemic lupus erythematosus: current concepts.
Nalbandian A; Crispín JC; Tsokos GC
Clin Exp Immunol; 2009 Aug; 157(2):209-15. PubMed ID: 19604260
[TBL] [Abstract][Full Text] [Related]
5. Elevated interleukin-25 and its association to Th2 cytokines in systemic lupus erythematosus with lupus nephritis.
Selvaraja M; Abdullah M; Arip M; Chin VK; Shah A; Amin Nordin S
PLoS One; 2019; 14(11):e0224707. PubMed ID: 31697750
[TBL] [Abstract][Full Text] [Related]
6. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
7. Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus.
Martin JC; Baeten DL; Josien R
Clin Immunol; 2014 Sep; 154(1):1-12. PubMed ID: 24858580
[TBL] [Abstract][Full Text] [Related]
8. Role of T helper 17 cells in the pathogenesis of systemic lupus erythematosus.
Abou Ghanima AT; Elolemy GG; Ganeb SS; Abo Elazem AA; Abdelgawad ER
Egypt J Immunol; 2012; 19(2):25-33. PubMed ID: 23885404
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17-producing T cells in lupus.
Crispín JC; Tsokos GC
Curr Opin Rheumatol; 2010 Sep; 22(5):499-503. PubMed ID: 20592603
[TBL] [Abstract][Full Text] [Related]
10. IL-17 promotes murine lupus.
Amarilyo G; Lourenço EV; Shi FD; La Cava A
J Immunol; 2014 Jul; 193(2):540-3. PubMed ID: 24920843
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of IL-27 in systemic lupus erythematosus.
Pan HF; Tao JH; Ye DQ
Expert Opin Ther Targets; 2010 May; 14(5):479-84. PubMed ID: 20350048
[TBL] [Abstract][Full Text] [Related]
13. miR-155 Deficiency Ameliorates Autoimmune Inflammation of Systemic Lupus Erythematosus by Targeting S1pr1 in Faslpr/lpr Mice.
Xin Q; Li J; Dang J; Bian X; Shan S; Yuan J; Qian Y; Liu Z; Liu G; Yuan Q; Liu N; Ma X; Gao F; Gong Y; Liu Q
J Immunol; 2015 Jun; 194(11):5437-45. PubMed ID: 25911753
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus.
Terrier B; Costedoat-Chalumeau N; Garrido M; Geri G; Rosenzwajg M; Musset L; Klatzmann D; Saadoun D; Cacoub P
J Rheumatol; 2012 Sep; 39(9):1819-28. PubMed ID: 22859347
[TBL] [Abstract][Full Text] [Related]
15. IL-17 in systemic lupus erythematosus.
Crispín JC; Tsokos GC
J Biomed Biotechnol; 2010; 2010():943254. PubMed ID: 20379379
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-25 is upregulated in patients with systemic lupus erythematosus and ameliorates murine lupus by inhibiting inflammatory cytokine production.
Li Y; Wang R; Liu S; Liu J; Pan W; Li F; Li J; Meng D
Int Immunopharmacol; 2019 Sep; 74():105680. PubMed ID: 31200339
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17 in systemic lupus erythematosus: A comprehensive review.
Li D; Guo B; Wu H; Tan L; Chang C; Lu Q
Autoimmunity; 2015; 48(6):353-61. PubMed ID: 25894789
[TBL] [Abstract][Full Text] [Related]
18. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.
Wong CK; Lit LC; Tam LS; Li EK; Wong PT; Lam CW
Clin Immunol; 2008 Jun; 127(3):385-93. PubMed ID: 18373953
[TBL] [Abstract][Full Text] [Related]
19. APRIL levels strongly correlate with IL-17 in systemic lupus erythematosus.
Eilertsen GØ; Nossent JC
Lupus; 2014 Nov; 23(13):1383-91. PubMed ID: 25057039
[TBL] [Abstract][Full Text] [Related]
20. Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis.
AlFadhli S; AlFailakawi A; Ghanem AA
Int J Rheum Dis; 2016 May; 19(5):512-20. PubMed ID: 25496163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
